Cargando…

Renal Morbidity of 6% Hydroxyethyl Starch 130/0.4 in 9000 Propensity Score Matched Pairs of Surgical Patients

Several studies of critically ill patients reported that fluid resuscitation with hydroxyethyl starch (HES) solutions damages the kidneys, but their use for surgical patients is debated. Because different HES preparations have different safety profiles, we sought to determine whether 6% third-genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyao, Hideki, Kotake, Yoshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Featured Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249485/ https://www.ncbi.nlm.nih.gov/pubmed/31856004 http://dx.doi.org/10.1213/ANE.0000000000004592

Ejemplares similares

Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study
por: Miyao, Hideki, et al.
Publicado: (2020)

Is hydroxyethyl starch 130/0.4 safe?
por: Haase, Nicolai, et al.
Publicado: (2012)

The impact of 30 ml/kg hydroxyethyl starch 130/0.4 vs hydroxyethyl starch 130/0.42 on coagulation in patients undergoing abdominal surgery
por: Staikou, Chryssoula, et al.
Publicado: (2012)

Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
por: Oh, Chung-Sik, et al.
Publicado: (2012)

Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
por: Piazza, Ornella, et al.
Publicado: (2010)

Interactions between the volume effects of hydroxyethyl starch 130/0.4 and Ringer´s acetate
por: Hahn, Robert G, et al.
Publicado: (2013)

Effects of hydroxyethyl starch 130/0.4 on the kidney tissue of rats with ureteral obstruction
por: Güneş, Işın, et al.
Publicado: (2018)

Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis
por: Van der Linden, Philippe, et al.
Publicado: (2015)

In vivo effect of hydroxyethyl starch solution (HES 130/0.4) on different fibrinogen assays
por: Schött, U, et al.
Publicado: (2014)

Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
por: Kasper, SM, et al.
Publicado: (2002)

Evaluation of effectiveness and safety of hydroxyethyl starch (HES 130 kDa/0.4) in burn resuscitation
por: Mokline, A, et al.
Publicado: (2012)

Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion
por: Han, Junliang, et al.
Publicado: (2012)

Hydroxyethyl starch 130/0.4 or hypertonic saline solution to decrease inflammatory response in hemorrhagic shock?
por: Esnault, Pierre, et al.
Publicado: (2013)

Resuscitation with hydroxyethyl starch 130/0.4 attenuates intestinal injury in a rabbit model of sepsis
por: Lu, Wei-Hua, et al.
Publicado: (2015)

Comparison of Hydroxyethyl starch 130/0.4 (6%) with commonly used agents in an experimental Pleurodesis model
por: Kapicibasi, Hasan Oğuz, et al.
Publicado: (2020)

The effects of hydroxyethyl starch 130/0.4 on perioperative renal function in patients undergoing cardiac surgery: A randomised controlled trial
por: Nagaya, Kei, et al.
Publicado: (2022)

Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin
por: Chen, Gan, et al.
Publicado: (2013)

Blood substitutes consumption and coagulation changes: 200/0.5 vs 130/0.4 hydroxyethyl starch administration
por: Costa, MG, et al.
Publicado: (2003)

Hydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicentre safety study
por: Lochbühler, H, et al.
Publicado: (2003)

Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited
por: Wiedermann, Christian J.
Publicado: (2022)

Effects of Hydroxyethyl Starch 130/0.4 on Serum Creatinine Concentration and Development of Acute Kidney Injury in Nonazotemic Cats
por: Sigrist, N.E., et al.
Publicado: (2017)

Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction
por: Trentini, Alessandro, et al.
Publicado: (2019)

Stage 1-Biomarkers of Kidney Injury in Dogs Undergoing Constant Rate Infusion of Hydroxyethyl Starch 130/0.4
por: Bruno, Barbara, et al.
Publicado: (2021)

Biomarkers of Coagulation and Inflammation in Dogs after Randomized Administration of 6% Hydroxyethyl Starch 130/0.4 or Hartmann’s Solution
por: Boyd, Corrin J., et al.
Publicado: (2022)

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
por: Wiedermann, Christian J
Publicado: (2016)

The dose of hydroxyethyl starch 6% 130/0.4 for fluid therapy and the incidence of acute kidney injury after cardiac surgery: A retrospective matched study
por: Momeni, Mona, et al.
Publicado: (2017)

Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation Following Complex Heart Surgery
por: Cho, Jang-Eun, et al.
Publicado: (2014)

Adverse effects of hydroxyethyl starch (HES 130/0.4) on intestinal barrier integrity and metabolic function are abrogated by supplementation with Albumin
por: Wong, Yuk Lung, et al.
Publicado: (2016)

Thromboelastometric assessment of hemostasis following hydroxyethyl starch (130/0.4) administration as a constant rate infusion in hypoalbuminemic dogs
por: Botto, Angelica, et al.
Publicado: (2018)

Evaluation of renal injury caused by acute volume replacement with hydroxyethyl starch 130/0.4 or Ringer's lactate solution in pigs
por: Ferreira, David A., et al.
Publicado: (2018)

Advantages of 6% hydroxyethyl starch 130/0.4 (Voluven(®)) at repetitive high dose levels in patients with severe cranio-cerebral trauma
por: Neff, ThA, et al.
Publicado: (2001)

Effect of acute hypervolemic hemodilution of 6% hydroxyethyl starch 130/0.4 on the EC(50) of propofol at two clinical endpoints in patients
por: LI, YUHONG, et al.
Publicado: (2016)

The comparison of albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials
por: Wei, Ling, et al.
Publicado: (2021)

Effect of 6% hydroxyethyl starch 130/0.4 on kidney and haemostatic function in cardiac surgical patients: a randomised controlled trial
por: Duncan, A. E., et al.
Publicado: (2020)

Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis
por: Khan, Shariq A, et al.
Publicado: (2013)

Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study
por: Gurbuz, Hasan Alper, et al.
Publicado: (2013)

6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice
por: Margraf, Andreas, et al.
Publicado: (2018)

Blood acid–base, haematological and haemostatic effects of hydroxyethyl starch (130/0.4) compared to succinylated gelatin colloid infusions in normovolaemic dogs
por: Buck, Roxanne K., et al.
Publicado: (2020)

Assessment of Hydroxyethyl Starch (6% HES 130/0.4) Kidney Storage in Critically Ill Dogs: A Post-mortem Prospective Study
por: Adamik, Katja-Nicole, et al.
Publicado: (2022)

Hydroxyethyl starch 130/0.4 for volume replacement therapy in surgical patients: a systematic review and meta-analysis of randomized controlled trials
por: Xu, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sv53pvp4an1g56adp0u4k17jl9